People

Sergio Quezada

droiaventures.com

Sergio Quezada is named Investment Advisory Board in Droia’s current public directory. The published professional background includes Professor of Cancer Immunology and Immunotherapy at UCL Cancer Institute; Group Leader of the Immune Regulation and Tumour Immunotherapy Laboratory; CRUK Senior Cancer Research Fellow; Co-leading scientist CRUK Cancer Immunotherapy Accelerator; CSO at Achilles Therapeutics. This is a manager-published affiliation; advisory-board membership and Droia Labs scientific roles are qualified separately from the investment team. Exact appointment dates and personal cash participation are not inferred.